trending Market Intelligence /marketintelligence/en/news-insights/trending/QE_nHrYxALXOP9lu4r42sw2 content esgSubNav
In This List

Novartis sells Indian rights to some medicine brands

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Novartis sells Indian rights to some medicine brands

Novartis AG sold the Indian rights to some of its medicine brands to Mauritius-based private equity firm Samara Capital Inc., a company spokesperson said.

The sale includes the rights to Cofvector, Monkezin and Glyred along with exclusive licenses to Curam, Foristal and Gretacal.

The financial terms of the deal were not disclosed.